Clinical trial protocols lay the foundation for R&D, but they aren’t enough to ensure success. People, processes, and ...

Ultimately, the data and technology systems validation capability can become a strategic differentiator that enables faster ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

Automation consistently comes up to help tackle today’s complexity in clinical trials, but there are different ideas of what it is and where it is useful. We asked several leaders in trial operations, ...

With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.

The Keck School of Medicine of USC has joined the Ryght Research Network, a global network of academic institutions, community practices and health care systems that uses generative artificial ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Flow cytometry has become a key analytical technique in clinical trials. Through its multiparametric analysis, single-cell resolution, and high-throughput evaluation capabilities, flow cytometry can ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...